Advisory Services Network, LLC Arvinas, Inc. Transaction History

Advisory Services Network, LLC

  • $4.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$14.19 - $42.33 $1,944 - $5,799
137 New
137 $5,000
Q4 2022

Feb 13, 2023
BUY
$32.47 - $57.24 $97 - $171
3 New
3 $0
Q1 2021

May 24, 2021
SELL
$58.19 - $91.37 $65,347 - $102,608
-1,123 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$20.19 - $84.93 $22,673 - $95,376
1,123 New
1,123 $95,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email